MatriSys Bioscience, Inc. logo — Harnessing beneficial bacteria to treat chronic inflammatory...

MatriSys Bioscience, Inc.

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Founded 2015 United States La Jolla, United States 6 employees Convertible Note Total: $4.50M Biopharma, Biotechnology +2

General Information

Company Name MatriSys Bioscience, Inc.
Founded Year 2015
Location United States La Jolla, United States +1
Founders / Decision Makers
Team member
Employees 6
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Convertible Note
Social

Get notified when MatriSys Bioscience, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MatriSys Bioscience, Inc.

MatriSys Bioscience, Inc. is a clinical stage Specialty Biopharmaceutical Company that focuses on harnessing beneficial bacteria to treat chronic inflammatory skin conditions. The company is targeting the $142 Billion WW dermatology and skin care market by developing therapies for top skin conditions such as Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which collectively affect over 230 million patients. This represents a substantial $12.9 Billion Rx market and a $121 Billion skin care market. MatriSys Bio’s approach involves rebalancing the natural skin microbiome using microbial therapies, specifically targeting "Bad Bugs" with "Good Bugs." The company's lead microbiome Phase I/II clinical program, addressing the Atopic Dermatitis market, is particularly promising as it targets 15 M US patients and 132 M worldwide. This program is NIH funded and protected with an exclusive license from UCSD. The recent $3.00MConvertible Note investment on 11 March 2021 from Tech Coast Angels and Primer Capital highlights the confidence of prominent investors in MatriSys Bioscience's potential to revolutionize the dermatology and skin care market. With a strong scientific foundation, significant market potential, and strategic partnerships, MatriSys Bioscience, Inc. is positioned as an innovative player in the biopharma and biotechnology space.

Taxonomy: Specialty Biopharmaceutical Company, Dermatology, Skin care, Microbiome Therapies, Atopic Dermatitis, Rosacea, Psoriasis, Acne, Skin Infections, Live Biotherapeutic Products, Biopharmaceutical product development, Cosmeceutics, Clinical Stage Company, NIH funded, IP protection

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 2
Investor Investor
11 Mar 2021
Venture Round •••••• 2
Investor Investor
01 Oct 2019
Seed Round •••••• 2
Investor Investor
08 Oct 2018
Convertible Note •••••• 1
Investor
05 Jan 2017

MatriSys Bioscience, Inc. Alternatives & Competitors

MatriSys Bioscience, Inc. vs

Helping people with skin irritations and disorders (atopic dermatitis, eczema) through holistic skin...

Non Equity Assistance
1 employees
Wellness Beauty

FAQ About MatriSys Bioscience, Inc.

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.
MatriSys Bioscience, Inc. was founded in 2015.
MatriSys Bioscience, Inc. is headquartered in La Jolla, United States.
MatriSys Bioscience, Inc. operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
MatriSys Bioscience, Inc. has approximately 6 employees.
MatriSys Bioscience, Inc. has completed 4 funding rounds, raising a total of $4.50M. The latest funding stage is Convertible Note.
Top alternatives and competitors to MatriSys Bioscience, Inc. include HerBiome Skincare Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MatriSys Bioscience, Inc. and HerBiome Skincare Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MatriSys Bioscience, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy